Stephen Grote, PA
Physician Assistant · Fort Wayne, INNPI 1689283327
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,036 of the $12,010 with a category attached, or 83.6%. 44 manufacturers reported payments, led by Livanova USA, Inc. at 24.6% of the total. Reporting peaked in 2021 at $3,915 and has fallen 83.8% since, to $635 in 2025. Among physician assistant clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 603 payments — averaging $19.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$3K
- AbbVie$2K
- Medtronic$864
- SK Life Science, Inc.$530
- Teva Pharmaceuticals USA, Inc.$465
- Biohaven Pharmaceuticals, Inc.$435
- plus $5K from 38 others
What the payments were for
- Travel & lodging$1,97416%
- Food & beverage$10,03684%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$1,509
- VNS - Sentiva$585
- PERCEPT PC BRAINSENSE$554
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$250
- NURTEC ODT$233
- VALTOCO$207
- INFINITY$142
- Leqembi$123
- UBRELVY$123
- XCOPRI$122
- AUSTEDO$122
- AJOVY$118
How this compares
$12,010 in reported general payments places this provider in the 95th percentile of 1,955 physician assistant providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XcopriCenobamate | 186 | $242,860 |
| IngrezzaValbenazine Tosylate | 26 | $225,603 |
| UbrelvyUbrogepant | 100 | $170,243 |
| Emgality PenGalcanezumab-Gnlm | 146 | $139,663 |
| BriviactBrivaracetam | 88 | $133,616 |
| VimpatLacosamide | 44 | $77,991 |
| NuplazidPimavanserin Tartrate | 14 | $68,397 |
| LamictalLamotrigine | 21 | $66,995 |
| QuliptaAtogepant | 46 | $62,443 |
| Nurtec OdtRimegepant Sulfate | 40 | $59,040 |
| AptiomEslicarbazepine Acetate | 43 | $58,132 |
| TopamaxTopiramate | 38 | $57,983 |
| Lacosamide | 333 | $48,709 |
| KeppraLevetiracetam | 35 | $48,194 |
| OnfiClobazam | 12 | $42,244 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| SK Life Science, Inc.Xcopri | $530 | $242,860186 claims |
| AbbVieUbrelvy, Qulipta | $1,781 | $232,686146 claims |
| UCB, Inc.Briviact, Vimpat, Neupro | $394 | $230,256146 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $116 | $225,60326 claims |
| PfizerNurtec Odt, Dilantin, Lyrica | $137 | $74,63791 claims |
| Acadia Pharmaceuticals IncNuplazid | $425 | $68,39714 claims |
| Lundbeck LLCOnfi | $13 | $42,24412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,955 physician assistant providers in Indiana.
Other physician assistant in Fort Wayne
- A FergusonFort Wayne$22K
- Jacquelyn BeemerFort Wayne$21K
- Dana LingelFort Wayne$14K
- Guinevere NillesFort Wayne$12K
- Kristen GumpfCarmel$142K
- Andrew NordIndianapolis$47K
- Qun Ming ZhangIndianapolis$28K
- Lauren HoweMunster$28K
- Lindsay YoderIndianapolis$21K
- Eryn GormanClinton$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.